MedPath

Follow-up study of "Evaluation for new Phosphate Iron-based binder, Sucroferric Oxyhydroxide in Dialysis patient for E.B.M (EPISODE)"

Not Applicable
Conditions
hyperphosphatemia
Registration Number
JPRN-UMIN000043661
Lead Sponsor
Osaka University Graduate School of Medicine Department of Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
156
Inclusion Criteria

Not provided

Exclusion Criteria

Research investigators or research sharing investigators have determined to the patient is inappropriate as a subject of the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath